The need to develop new therapeutic strategies in RA led us to apply a gene therapy system to transfer IL-35 gene in CIA. We thus aimed at evaluating the therapeutic potential of IL-35 encoding plasmid electrotransfer in this model and at evaluating its cellular mode of action.